STOCK TITAN

Stock option grant for Cibus (CBUS) director Rory B. Riggs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cibus, Inc. director Rory B. Riggs reported receiving a grant of stock options. The award covers 77,586 options to buy Class A common stock at an exercise price of $1.39 per share, expiring on June 2, 2036.

According to the terms, these options vest in full, subject to his continued service, on the earlier of the first anniversary of the June 2, 2026 grant date or the company’s next annual meeting of shareholders. Following this grant, Riggs holds 77,586 derivative securities directly.

Positive

  • None.

Negative

  • None.
Insider RIGGS RORY B
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right-to-Buy) 77,586 $0.00 --
Holdings After Transaction: Stock Option (Right-to-Buy) — 77,586 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 77,586 options Stock Option (Right-to-Buy) grant to director Rory B. Riggs
Exercise price $1.39 per share Conversion or exercise price of options for Class A Common Stock
Underlying shares 77,586 shares Underlying Class A Common Stock tied to the stock options
Post-grant derivative holdings 77,586 derivative securities Total options held following the reported transaction
Option expiration June 2, 2036 Expiration date of the granted stock options
Stock Option (Right-to-Buy) financial
"security_title: "Stock Option (Right-to-Buy)""
Class A Common Stock financial
"underlying_security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
grant date financial
"the earlier of (1) the first anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
expiration date financial
"expiration_date: "2036-06-02T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RIGGS RORY B

(Last)(First)(Middle)
6455 NANCY RIDGE DRIVE

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Cibus, Inc. [ CBUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right-to-Buy)$1.3906/02/2026A77,58606/02/2027(1)06/02/2036Class A Common Stock77,586$077,586D
Explanation of Responses:
1. The Options vest in full, subject to the Director's continued service, the earlier of (1) the first anniversary of the grant date and (2) the date of the Company's next annual meeting of shareholders.
Jason Stokes, Attorney-in-Fact for Rory B. Riggs06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cibus (CBUS) director Rory Riggs report?

Rory B. Riggs reported receiving a grant of stock options in Cibus, Inc. The award covers 77,586 options for Class A common stock, reflecting compensation rather than an open-market purchase or sale of existing shares.

How many Cibus (CBUS) stock options were granted to Rory Riggs and at what price?

Rory B. Riggs was granted 77,586 stock options in Cibus, Inc. Each option has an exercise price of $1.39 per share, giving him the right to buy Class A common stock at that fixed price.

When do Rory Riggs’ Cibus (CBUS) stock options vest?

The options vest in full on the earlier of the first anniversary of the grant date or the date of Cibus, Inc.’s next annual meeting of shareholders, provided Rory Riggs continues to serve as a director until vesting.

What is the expiration date of the Cibus (CBUS) stock options granted to Rory Riggs?

The stock options granted to Rory B. Riggs expire on June 2, 2036. After that date, any unexercised options will lapse, meaning they can no longer be used to purchase Cibus Class A common shares at the $1.39 exercise price.

Is Rory Riggs’ Cibus (CBUS) option grant an open-market buy or sell?

No, the reported transaction is a grant or award of options, coded “A” on Form 4. It is a compensation-related acquisition of derivative securities, not an open-market purchase or sale of Cibus common stock.